Attention Deficit and Disruptive Behavior Disorders
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Examen neurologique : Questions médicales les plus fréquentes",
"headline": "Examen neurologique : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Examen neurologique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-05",
"dateModified": "2025-02-28",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Examen neurologique"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Examen physique",
"url": "https://questionsmedicales.fr/mesh/D010808",
"about": {
"@type": "MedicalCondition",
"name": "Examen physique",
"code": {
"@type": "MedicalCode",
"code": "D010808",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E01.370.600"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Échelle de mesure des mouvements involontaires anormaux",
"alternateName": "Abnormal Involuntary Movement Scale",
"url": "https://questionsmedicales.fr/mesh/D000067399",
"about": {
"@type": "MedicalCondition",
"name": "Échelle de mesure des mouvements involontaires anormaux",
"code": {
"@type": "MedicalCode",
"code": "D000067399",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E01.370.600.550.162"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Mesure de la douleur",
"alternateName": "Pain Measurement",
"url": "https://questionsmedicales.fr/mesh/D010147",
"about": {
"@type": "MedicalCondition",
"name": "Mesure de la douleur",
"code": {
"@type": "MedicalCode",
"code": "D010147",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E01.370.600.550.324"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Examen neurologique",
"alternateName": "Neurologic Examination",
"code": {
"@type": "MedicalCode",
"code": "D009460",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Lizabeth C Lueck",
"url": "https://questionsmedicales.fr/author/Lizabeth%20C%20Lueck",
"affiliation": {
"@type": "Organization",
"name": "University of Wisconsin-Madison, Madison, Wisconsin, USA."
}
},
{
"@type": "Person",
"name": "Starr Cameron",
"url": "https://questionsmedicales.fr/author/Starr%20Cameron",
"affiliation": {
"@type": "Organization",
"name": "University of Wisconsin-Madison, Madison, Wisconsin, USA."
}
},
{
"@type": "Person",
"name": "Natalia Zidan",
"url": "https://questionsmedicales.fr/author/Natalia%20Zidan",
"affiliation": {
"@type": "Organization",
"name": "University of Wisconsin-Madison, Madison, Wisconsin, USA."
}
},
{
"@type": "Person",
"name": "Jochen Brich",
"url": "https://questionsmedicales.fr/author/Jochen%20Brich",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurology and Neuroscience, Medical Center, University of Freiburg, Freiburg, Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Exploring real-time functional magnetic resonance imaging neurofeedback in adolescents with disruptive behavior disorder and callous unemotional traits.",
"datePublished": "2023-10-16",
"url": "https://questionsmedicales.fr/article/37852585",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jad.2023.10.036"
}
},
{
"@type": "ScholarlyArticle",
"name": "The conduct and oppositional defiant disorder scales (CODDS) for disruptive behaviour disorders.",
"datePublished": "2022-07-23",
"url": "https://questionsmedicales.fr/article/35961152",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.psychres.2022.114744"
}
},
{
"@type": "ScholarlyArticle",
"name": "Short-Term Impact of \"Amaka Amasanyufu\" Multiple Family Group Intervention on Mental Health Functioning of Children With Disruptive Behavior Disorders in Uganda.",
"datePublished": "2023-03-08",
"url": "https://questionsmedicales.fr/article/36898607",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jaac.2022.12.028"
}
},
{
"@type": "ScholarlyArticle",
"name": "Some critical comments on the paper titled \"Some critical considerations in applying the construct of psychopathy to research and classification of childhood disruptive behavior disorders\".",
"datePublished": "2022-10-21",
"url": "https://questionsmedicales.fr/article/36328895",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.cpr.2022.102214"
}
},
{
"@type": "ScholarlyArticle",
"name": "Polygenic risk scores for antisocial behavior in relation to amygdala morphology across an attention deficit hyperactivity disorder case-control sample with and without disruptive behavior.",
"datePublished": "2022-07-30",
"url": "https://questionsmedicales.fr/article/35914510",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.euroneuro.2022.07.182"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Diagnostic",
"item": "https://questionsmedicales.fr/mesh/D003933"
},
{
"@type": "ListItem",
"position": 3,
"name": "Techniques et procédures diagnostiques",
"item": "https://questionsmedicales.fr/mesh/D019937"
},
{
"@type": "ListItem",
"position": 4,
"name": "Examen physique",
"item": "https://questionsmedicales.fr/mesh/D010808"
},
{
"@type": "ListItem",
"position": 5,
"name": "Examen neurologique",
"item": "https://questionsmedicales.fr/mesh/D009460"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Examen neurologique - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Examen neurologique",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-14",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Examen neurologique",
"description": "Quels tests sont utilisés lors d'un examen neurologique ?\nComment évaluer la fonction cognitive ?\nQu'est-ce qu'un examen neurologique complet ?\nQuand un examen neurologique est-il nécessaire ?\nQuel rôle joue l'imagerie dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D009460?mesh_terms=Attention+Deficit+and+Disruptive+Behavior+Disorders&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Examen neurologique",
"description": "Quels sont les symptômes d'une lésion nerveuse ?\nComment reconnaître un AVC ?\nQuels symptômes indiquent une maladie neurodégénérative ?\nQuels signes peuvent indiquer une migraine ?\nQuels symptômes sont associés à la sclérose en plaques ?",
"url": "https://questionsmedicales.fr/mesh/D009460?mesh_terms=Attention+Deficit+and+Disruptive+Behavior+Disorders&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Examen neurologique",
"description": "Comment prévenir les AVC ?\nQuelles mesures pour éviter les migraines ?\nComment réduire le risque de maladies neurodégénératives ?\nQuelles sont les stratégies de prévention pour la neuropathie ?\nComment prévenir les blessures à la tête ?",
"url": "https://questionsmedicales.fr/mesh/D009460?mesh_terms=Attention+Deficit+and+Disruptive+Behavior+Disorders&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Examen neurologique",
"description": "Quels traitements sont disponibles pour les migraines ?\nComment traiter une neuropathie périphérique ?\nQuelles sont les options pour l'AVC ?\nComment gérer les symptômes de la sclérose en plaques ?\nQuels traitements sont efficaces pour les troubles de l'humeur ?",
"url": "https://questionsmedicales.fr/mesh/D009460?mesh_terms=Attention+Deficit+and+Disruptive+Behavior+Disorders&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Examen neurologique",
"description": "Quelles complications peuvent survenir après un AVC ?\nQuels risques sont associés à la sclérose en plaques ?\nQuelles complications peuvent résulter d'une neuropathie ?\nQuels effets secondaires des traitements neurologiques ?\nQuelles complications psychologiques peuvent survenir ?",
"url": "https://questionsmedicales.fr/mesh/D009460?mesh_terms=Attention+Deficit+and+Disruptive+Behavior+Disorders&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Examen neurologique",
"description": "Quels sont les facteurs de risque pour les AVC ?\nQuels facteurs augmentent le risque de migraines ?\nQuels sont les facteurs de risque pour la sclérose en plaques ?\nQuels facteurs influencent la neuropathie ?\nQuels sont les facteurs de risque pour les troubles de l'humeur ?",
"url": "https://questionsmedicales.fr/mesh/D009460?mesh_terms=Attention+Deficit+and+Disruptive+Behavior+Disorders&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Quels tests sont utilisés lors d'un examen neurologique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent l'évaluation des réflexes, la force musculaire et la coordination."
}
},
{
"@type": "Question",
"name": "Comment évaluer la fonction cognitive ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "La fonction cognitive est évaluée par des tests de mémoire, d'attention et de langage."
}
},
{
"@type": "Question",
"name": "Qu'est-ce qu'un examen neurologique complet ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il inclut l'évaluation des nerfs crâniens, de la motricité et de la sensibilité."
}
},
{
"@type": "Question",
"name": "Quand un examen neurologique est-il nécessaire ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est nécessaire en cas de symptômes neurologiques comme des maux de tête ou des vertiges."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'imagerie dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'imagerie, comme l'IRM, aide à visualiser les anomalies cérébrales ou médullaires."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une lésion nerveuse ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent engourdissement, faiblesse musculaire et douleurs neuropathiques."
}
},
{
"@type": "Question",
"name": "Comment reconnaître un AVC ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent une faiblesse soudaine, des troubles de la parole et des maux de tête."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une maladie neurodégénérative ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des troubles de la mémoire, des changements de comportement et des tremblements."
}
},
{
"@type": "Question",
"name": "Quels signes peuvent indiquer une migraine ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent des douleurs unilatérales, des nausées et une sensibilité à la lumière."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont associés à la sclérose en plaques ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fatigue, troubles de la vision et problèmes d'équilibre."
}
},
{
"@type": "Question",
"name": "Comment prévenir les AVC ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut un mode de vie sain, le contrôle de la pression artérielle et l'arrêt du tabac."
}
},
{
"@type": "Question",
"name": "Quelles mesures pour éviter les migraines ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les déclencheurs, maintenir une bonne hydratation et gérer le stress peuvent aider."
}
},
{
"@type": "Question",
"name": "Comment réduire le risque de maladies neurodégénératives ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie actif, une alimentation équilibrée et des activités cognitives peuvent aider."
}
},
{
"@type": "Question",
"name": "Quelles sont les stratégies de prévention pour la neuropathie ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Contrôler le diabète, éviter l'alcool et maintenir une bonne nutrition sont essentiels."
}
},
{
"@type": "Question",
"name": "Comment prévenir les blessures à la tête ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Porter un casque, éviter les activités à risque et sécuriser l'environnement sont cruciaux."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les migraines ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des analgésiques, des médicaments préventifs et des thérapies comportementales."
}
},
{
"@type": "Question",
"name": "Comment traiter une neuropathie périphérique ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement peut inclure des médicaments pour la douleur, la physiothérapie et des changements de mode de vie."
}
},
{
"@type": "Question",
"name": "Quelles sont les options pour l'AVC ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les options incluent des médicaments thrombolytiques et la réhabilitation post-AVC."
}
},
{
"@type": "Question",
"name": "Comment gérer les symptômes de la sclérose en plaques ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion inclut des médicaments immunomodulateurs et des thérapies physiques."
}
},
{
"@type": "Question",
"name": "Quels traitements sont efficaces pour les troubles de l'humeur ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la psychothérapie, les antidépresseurs et les thérapies cognitives."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après un AVC ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des troubles de la parole, des problèmes de mobilité et des infections."
}
},
{
"@type": "Question",
"name": "Quels risques sont associés à la sclérose en plaques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les risques incluent des infections, des complications urinaires et des problèmes de mobilité."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent résulter d'une neuropathie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des blessures dues à une perte de sensation et des infections."
}
},
{
"@type": "Question",
"name": "Quels effets secondaires des traitements neurologiques ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure des nausées, des vertiges et des troubles de l'humeur."
}
},
{
"@type": "Question",
"name": "Quelles complications psychologiques peuvent survenir ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent l'anxiété, la dépression et des troubles du sommeil."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les AVC ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'hypertension, le diabète, le tabagisme et l'obésité."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de migraines ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent le stress, les changements hormonaux et certains aliments."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour la sclérose en plaques ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, le sexe féminin et des antécédents familiaux."
}
},
{
"@type": "Question",
"name": "Quels facteurs influencent la neuropathie ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diabète, l'alcoolisme et certaines carences nutritionnelles sont des facteurs clés."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les troubles de l'humeur ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, le stress et des événements traumatiques."
}
}
]
}
]
}
Adolescents with increased callous unemotional traits (CU traits) in the context of disruptive behavior disorder (DBD) show a persistent pattern of antisocial behavior with shallow affect and a lack o...
In this explorative randomized controlled trial we randomly assigned twenty-seven adolescents with DBD to individualized real-time functional magnetic resonance neurofeedback (rtfMRI-NF) or behavioral...
The rtfMRI-NF (n = 11) and TAU (n = 10) completers showed comparable and significant clinical improvement indicating neither superiority nor inferiority of rtfMRI-NF. The exploratory LMM revealed succ...
This exploratory study demonstrated feasibility and suggests clinical efficacy of individualized rtfMRI-NF comparable to active TAU for adolescents with DBD and increased CU traits. Further studies ar...
This study evaluates the clinical validity of a five-minute instrument, the Conduct and Oppositional Defiant Disorder Scales (CODDS), for assessing oppositional defiant disorder (ODD) and conduct diso...
We evaluate the mid-intervention (8 weeks) and short-term (16 weeks) impact of a culturally adapted multiple family group (MFG) intervention, "Amaka Amasanyufu," on the mental health of children with ...
We analyzed data from the Strengthening mental health and research training in Sub-Saharan Africa (SMART) Africa-Uganda study. Schools were randomized to the following: a control group; an MFG facilit...
There were significant group-by-time interactions for all outcomes, and differences were observed mid-intervention, with short-term effects at 16 weeks (end-intervention). MFG-PP and MFG-CHW children ...
Amaka Amasanyufu MFG intervention is effective for reducing depressive symptoms and improving self-concept among children with DBDs while reducing parental stress and mental health problems among care...
SMART Africa (Strengthening Mental Health Research and Training); https://clinicaltrials.gov/: NCT03081195....
Frick (2022) presented a narrative review of some literature and made several critical comments regarding the extension of the full psychopathy construct to research and classification of childhood di...
Antisocial and aggressive behaviors show considerable heritability and are central to disruptive behavior disorders (DBDs), but are also frequently observed in attention deficit hyperactivity disorder...
Previous research has found some peculiarities in sexual functioning of adults with attention deficit/hyperactivity disorder (ADHD). Using a set of questionnaires that had to be answered online, we as...
Attention-deficit/hyperactivity disorder (ADHD; also known as hyperkinetic disorder) is a common neurodevelopmental condition that affects children and adults worldwide. ADHD has a predominantly genet...
This study aimed to investigate social cognition and empathy properties in children among Disruptive Mood Dysregulation Disorder (DMDD) + Attention and Hyperactivity Disorder(ADHD); ADHD and healthy c...
Twenty-two children with DMDD were compared to matched 30 children with ADHD and 60 healthy controls. We administered Affective Reactivity Index (ARI), KaSi Empathy Scale, Kiddie-SADS, and Reading Min...
DMDD + ADHD group had lower performance in ToM skills and empathy than in two groups. The ARI scores were found to be statistically significantly higher in the DMDD group than in two groups. It was al...
These results might be important to understand the difficulties in social functioning and interpersonal relationship in children with DMDD and ADHD. Children with DMDD may attend specific therapeutic ...
The current study sought to examine whether psycholinguistic assessments could discriminate children and adolescents with developmental language disorder (DLD) from those with attention-deficit/hypera...
The Clinical Evaluation of Language Fundamentals-Screening Test (CELFST; Wiig et al., 2013), the Comprehensive Test of Phonological Processing (...
The presence of a language disorder (with or without ADHD) predicted poor performance across tasks. Children and adolescents with ADHD (combined vs. inattentive) only significantly differed in sight w...
The combination of comorbid ADHD + DLD did not appear to be associated with lower language abilities, sight word reading, or phonemic decoding relative to DLD alone. Reading efficiency was effective i...
To evaluate the prevalence and types of sleep problems and their correlations with melatonin content and behavior in Attention-Deficit Hyperactivity Disorder (ADHD) children....
Sleep in ADHD children and typically developing children (TD) aged 6-14 was assessed by the Sleep Disorders Scale for Children (SDSC) and actigraphy, salivary melatonin quantified by ELISA, and behavi...
ADHD children showed a higher frequency of sleep disturbances, higher sleep latency, and lower sleep efficiency than in the TD group. The ADHD group presented lower melatonin nocturnal content compare...
This study provides, for the first time, evidence that among the frequent sleep disturbances in ADHD, the disorders in initiating and maintaining sleep are associated with the low levels of melatonin ...